Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nematode latrophilin-like G protein-coupled receptors, most notably LAT-1, are members of the adhesion G protein-coupled receptor (aGPCR) family and serve as critical targets for the cyclooctadepsipeptide class of anthelmintics, such as emodepside and its precursor PF1022A (Saeger et al., 2001; Willson et al., 2004). These receptors are primarily expressed in the nematode nervous system and pharyngeal muscle, where they regulate essential physiological processes including feeding (pharyngeal pumping), locomotion, and egg-laying (Guest et al., 2007). In parasitic nematodes, LAT-1 is a primary mediator of emodepside's inhibitory effects on the pharynx, contributing to the drug's broad-spectrum efficacy against various helminths (Welz et al., 2011). The binding of emodepside to LAT-1 is thought to activate a G protein-mediated signaling cascade that facilitates the opening of SLO-1 potassium channels, leading to neuromuscular hyperpolarization and flaccid paralysis (Crisford et al., 2011). Because these receptors are distinct from those in mammalian hosts, they represent a selective and effective target for treating both soil-transmitted and filarial nematode infections (Hübner et al., 2021).
Emodepside acts as an agonist at the latrophilin-like receptor (LAT-1), an adhesion G protein-coupled receptor. Activation of LAT-1 triggers a G protein-mediated signaling cascade (likely involving Gq/11 and phospholipase C) that facilitates the opening of SLO-1 large-conductance calcium-activated potassium channels, leading to hyperpolarization of neurons and muscles, resulting in flaccid paralysis and inhibition of feeding (pharyngeal pumping) in nematodes (Saeger et al., 2001; Guest et al., 2007; Welz et al., 2011).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Latrophilin-like G protein-coupled receptor 1 (LAT-1) (LAT-1).